Context Therapeutics Inc (CNTX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	32.20% 0.1524	0.2247	0.2904	0.2933	0.3555
Operating Expenses	44.46% 3.9759	7.1579	6.4709	5.5856	7.0221
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	44.46% 3.9759	7.1579	6.4709	5.5856	7.0221
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	44.85% -3.8235	-6.9332	-6.1805	-5.2924	-6.6665
Net Interest Income/Expense	32.20% 0.1524	0.2247	0.2904	0.2933	0.3555
Nonoperating Income/Loss	105.46% 0.00335	-0.0614	0.0154	-0.0122	0.00269
Income/Loss From Continuing Operations Before Tax	32.20% 0.1524	0.2247	0.2904	-5.0113	-6.3083
Income/Loss From Continuing Operations After Tax	45.82% -3.6678	-6.7699	-5.8747	-5.0113	-6.3083
Net Income/Loss	45.82% -3.6678	-6.7699	-5.8747	-5.0113	-6.3083
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	15.97	-	15.97	15.97	15.97
Diluted Average Shares	15.97	-	15.97	15.97	15.97
Basic Earnings Per Share	45.24% -0.23	-0.42	-0.37	-0.31	-0.40
Diluted Earnings Per Share	45.24% -0.23	-0.42	-0.37	-0.31	-0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%